Saurashtra Cements Regulatory Approval

Board Meeting Date

Saurashtra Cements Board Meeting Date

Saurashtra Cement Ltd will hold a board meeting on 4th November 2026 to consider and approve its unaudited financial results for the quarter ended September 2026.

Other Announcement

Saurashtra Cements Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.

Management Change

Saurashtra Cements Management Change

Saurashtra Cement Ltd appointed Mr. Anurag Tiwari as Managing Director-Designate, effective 16th October 2026. This appointment is classified under Senior Management Personnel.

Legal & Regulatory

Saurashtra Cements Legal & Regulatory

Saurashtra Cement received a GST show cause notice from the Deputy Commissioner of State Tax demanding ₹3.83 Crore, which the company intends to contest.

Value

₹3.83 Cr

Credit Rating

Saurashtra Cements Credit Rating

ICRA Limited has reaffirmed the credit rating of [ICRA] BBB- (Stable) for bank facilities of Saurashtra Cement Limited aggregating to ₹404 Crore.

Business Update

Saurashtra Cements Business Update

Saurashtra Cement signed a Power Consumption Agreement and Share Purchase Agreement with Jamnagar Renewables Two Private Limited, acquiring an 8.86% stake for Rs 14.92 Crore.

Value

₹14.92 Cr

From

Jamnagar Renewables Two Private Limited

Execution

25 years

Wind-Solar Hybrid power

14.0 MW

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.